PKG inhibitor

Cell-permeable, irreversible caspase inhibitor

Designed to capture high-mannose, hybrid, and complex type glycosylated peptides from complex protein mixtures

Inhibitor of fibrinogen aggregation and fibrin polymerization

Plays important role in regulation of blood pressure

Competitively inhibits direct binding of fibroblasts to fibronectin

S1P3 receptor antagonist

α7 subtype-selective nAChR antagonist

Selective Smad3 inhibitor; inhibits TGF-βR1 signaling

PAR2 receptor agonist

Selective sst2 antagonist

Potent K2P2.1 (TREK-1) channel blocker

Potent K2P9.1 (TASK-3) channel blocker

Potent RET inhibitor

Wnt5a peptide mimetic

Inhibitor of Bax-mediated apoptosis

Potent parathyroid hormone (PTH) receptor agonist

PAD4 inhibitor

WDR5/MLL interaction inhibitor

Endogenous NOP agonist

Ryanodine receptor (RyR) inhibitor

Mitochondria VDAC modulator; also Ferroptosis activator

Selective blocker of inward-rectifier K+ channels

Fluorescent VMAT2 substrate

Nrf2 signaling activator

Deuterated olanzapine (Cat. No. 4349)

Shown to inhibit fibronectin binding to platelet-binding sites

Acts as a functional antagonist of inflammatory mediators

Shown to inhibit fibronectin function by binding to platelet-binding sites and to induce apoptosis in osteoblasts

Active in cell adhesion and cell-surface receptor binding and in stimulating cell migration